Sign Up to like & get
recommendations!
1
Published in 2021 at "Mayo Clinic proceedings"
DOI: 10.1016/j.mayocp.2020.12.038
Abstract: OBJECTIVE To assess present angiotensin-converting enzyme inhibitor (ACEI) and angiotensin receptor blocker (ARB) use among patients with proteinuric chronic kidney disease (CKD) and examine barriers limiting this guideline-concordant care. PATIENTS AND METHODS Using a nationwide…
read more here.
Keywords:
acei arb;
nephrology;
care;
arb use ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2023 at "Current vascular pharmacology"
DOI: 10.2174/1570161121666230314114549
Abstract: INTRODUCTION Angiotensin-converting enzyme inhibitors (ACEI), angiotensin receptor blockers (ARB), angiotensin receptor-neprilysin inhibitor (ARNI), and mineralocorticoid receptor antagonists (MRA) reduce mortality and hospitalizations in heart failure with reduced ejection fraction (HFrEF) but their use is limited…
read more here.
Keywords:
proportion trials;
ckd grades;
arb use;
acei arb ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Frontiers in Cardiovascular Medicine"
DOI: 10.3389/fcvm.2022.1003442
Abstract: Background Few studies have evaluated whether acute myocardial infarction (AMI) patients with relatively low blood pressure benefit from early ACEI/ARB use in the era of percutaneous coronary intervention (PCI). Objectives This study evaluated the associations…
read more here.
Keywords:
arb use;
early acei;
acei arb;